Lydia Greasley, Investment Analyst at EdenTree, takes us through the latest Amity Insight to be published by EdenTree. The Life Code takes a look at the companies and technologies on the cutting edge of medical science, and the ethical issues this raises. How do EdenTree, as a responsible and sustainable investor, respond to these whilst capitalising on the opportunity this growing area affords?